<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Tuesday, Jan. 29, 2008</title>
	<atom:link href="http://venturebeat.com/2008/01/29/life-sciences-briefing-tuesday-jan-29-2008/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2008/01/29/life-sciences-briefing-tuesday-jan-29-2008/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 20:47:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Wednesday, Jan. 30, 2008</title>
		<link>http://venturebeat.com/2008/01/29/life-sciences-briefing-tuesday-jan-29-2008/comment-page-1/#comment-762498</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Wednesday, Jan. 30, 2008</dc:creator>
		<pubDate>Wed, 30 Jan 2008 22:42:24 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/01/29/life-sciences-briefing-tuesday-jan-29-2008/#comment-762498</guid>
		<description>[...] investment. Clarian&#8217;s first investment was in the cancer-biomarker biotech CS-Keys, which we covered yesterday.  For more stories on VentureBeat Life Sciences, click here.Tagged co:Active Implants, co:Arbor [...]</description>
		<content:encoded><![CDATA[<p>[...] investment. Clarian&#8217;s first investment was in the cancer-biomarker biotech CS-Keys, which we covered yesterday.  For more stories on VentureBeat Life Sciences, click here.Tagged co:Active Implants, co:Arbor [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
